CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00867 CMS

Market Closed 03-20 16:08:48

13.490

-0.100

-0.74%

High13.940	Low13.410	Vol3.41M
Open13.560	D1 Closing13.590	Amplitude3.90%
Mkt Cap32.92B	Tradable Cap32.91B	Total Shares2.44B
T/O46.33M	T/O Rate0.14%	Tradable Shares2.44B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"CMS","latestPrice":13.49,"timestamp":1773994128003,"preClose":13.59,"halted":0,"volume":3405000,"delay":0,"changeRate":-0.00735835172921263,"floatShares":2439528512,"shares":2440000000,"eps":0.698142532986492,"marketStatus":"Market Closed","change":-0.1,"latestTime":"03-20 16:08:48","open":13.56,"high":13.94,"low":13.41,"amount":46326030,"amplitude":0.038999,"askPrice":13.5,"askSize":13000,"bidPrice":13.49,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.698142532986492,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":7,"adr":0,"listingDate":1285603200000,"exchange":"SEHK","adjPreClose":13.59,"dividendRate":0.022981,"openAndCloseTimeList":[[1773970200000,1773979200000],[1773982800000,1773993600000]],"volumeRatio":0.8764393489434225,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867","defaultTab":"news","newsList":[{"id":"2621758686","title":"China Medical System Wins Desidustat Approval Raising Nephrology Growth Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=2621758686","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621758686?lang=en_us&edition=fundamental","pubTime":"2026-03-20 23:10","pubTimestamp":1774019418,"startTime":"0","endTime":"0","summary":"China Medical System Holdings (SEHK:867) has received marketing approval in China for Desidustat Tablets, an oral treatment for renal anaemia in non dialysis chronic kidney disease patients.\nThe approval adds a new drug to the company’s nephrology portfolio and targets a major unmet medical need in China.\n\nChina Medical System Holdings is drawing fresh attention after this new approval, with the share price at HK$13.49 and a 1 year return of 81.4%. The stock has also seen a 6.1% gain over...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-wins-desidustat-approval-raising-nephro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-wins-desidustat-approval-raising-nephro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BYV24P56.USD","BK1593","SG9999015978.USD","IE00BVYPNP33.GBP","SG9999015952.SGD","SG9999015945.SGD","SG9999015986.USD","IE00BMCWC346.EUR","LU2488822045.USD","00867","IE00BGHQDM52.EUR","SG9999004220.SGD","BK1191","IE00BVYPNQ40.USD"],"gpt_icon":0},{"id":"2620574258","title":"China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2620574258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620574258?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:05","pubTimestamp":1773828329,"startTime":"0","endTime":"0","summary":"China Medical System Holdings (SEHK:867) has put fresh numbers on the table for FY 2025, posting first half revenue of C¥4.0b and basic EPS of C¥0.39, alongside trailing twelve month revenue of C¥7.9b and EPS of C¥0.68. The company has seen revenue move from C¥3.6b in the first half of FY 2024 to C¥4.0b in the first half of FY 2025 and trailing revenue shift from C¥7.5b to C¥7.9b, with basic EPS across reported halves ranging between C¥0.29 and C¥0.39. For you as an investor, the key question...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk-867-margin-decline-tests","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk-867-margin-decline-tests","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BMCWC346.EUR","SG9999015978.USD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","BK1191","BK1593","IE00BVYPNP33.GBP","BLSG","IE00BVYPNQ40.USD","SG9999015945.SGD","SG9999004220.SGD","SG9999015986.USD","LU2488822045.USD","00867","BLSX","SG9999015952.SGD","BK4112"],"gpt_icon":0},{"id":"1144733107","title":"Stock Track | CMS Soars 5.09% Intraday After Analyst Upgrade and Target Price Hike","url":"https://stock-news.laohu8.com/highlight/detail?id=1144733107","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144733107?lang=en_us&edition=fundamental","pubTime":"2026-03-18 13:45","pubTimestamp":1773812717,"startTime":"0","endTime":"0","summary":"CMS's stock price surged 5.09% during intraday trading on Wednesday, following a bullish research report from a major brokerage.The sharp rise came after CICC maintained its Outperform rating on CMS...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["00867"],"gpt_icon":0},{"id":"1117291615","title":"Analysts Maintain Outperform Rating on CMS, Raise Target Price to HK$17.50","url":"https://stock-news.laohu8.com/highlight/detail?id=1117291615","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117291615?lang=en_us&edition=fundamental","pubTime":"2026-03-18 11:02","pubTimestamp":1773802959,"startTime":"0","endTime":"0","summary":"CICC has released a research report stating that, considering the contribution from new product sales, it has raised its adjusted net profit forecast for CMS (00867) for 2026/2027 by 6%/9% to RMB...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNP33.GBP","BK1191","BK1593","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999015952.SGD","IE00BYV24P56.USD","SG9999015945.SGD","SG9999004220.SGD","LU2488822045.USD","00867","SG9999015978.USD"],"gpt_icon":0},{"id":"1109641295","title":"CMS (00867) 2025 Net Profit Normalised Up 3.6%; Turnover Rises 9.9% to RMB 8.21 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1109641295","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109641295?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:23","pubTimestamp":1773739430,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (CMS, 00867.HK; 8A8.SGX) released its audited results for the year ended 31 December 2025, marking the first set of annual results since its secondary listing in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"gpt_icon":0},{"id":"2620471774","title":"China Medical System Holdings - FY Turnover up 9.9% to RMB8,212.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2620471774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620471774?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:04","pubTimestamp":1773738274,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nFWN4040Z5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","IE00BYV24P56.USD","BK1593","SG9999004220.SGD","IE00BMCWC346.EUR","BK1191","00867","IE00BVYPNP33.GBP","SG9999015952.SGD","IE00BVYPNQ40.USD","SG9999015945.SGD","SG9999015978.USD","SG9999015986.USD","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"1126530827","title":"CMS (00867) Declares FY2025 Final Dividend of RMB 0.1366 (HKD 0.155) per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1126530827","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126530827?lang=en_us&edition=fundamental","pubTime":"2026-03-17 07:21","pubTimestamp":1773703282,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (CMS, 00867) has announced a final ordinary dividend of RMB 0.1366 per share for the financial year ended 31 December 2025. Based on the exchange rate of RMB 1:...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"gpt_icon":0},{"id":"2620249012","title":"China Medical System Holdings files list of directors with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2620249012","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620249012?lang=en_us&edition=fundamental","pubTime":"2026-03-17 07:04","pubTimestamp":1773702294,"startTime":"0","endTime":"0","summary":"China Medical System filed an updated list of directors with the Hong Kong Stock Exchange. The executive directors are Lam Kong  and Chen Yanling . The independent non-executive directors are Leung Chong Shun, Luo Laura Ying, and Fung Ching Simon. Leung Chong Shun chairs the remuneration committee and is a member of the audit, nomination, and environmental, social and governance committees. Fung Ching Simon chairs the audit committee, while Luo Laura Ying chairs the nomination committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 16, 2026, and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL855Szs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004220.SGD","BK1191","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","LU2488822045.USD","BK1593","SG9999015945.SGD","SG9999015978.USD","IE00BYV24P56.USD","SG9999015986.USD","00867","SG9999015952.SGD","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD"],"gpt_icon":0},{"id":"2620490131","title":"China Medical System Holdings proposes final dividend of RMB 0.1366 per share for FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2620490131","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620490131?lang=en_us&edition=fundamental","pubTime":"2026-03-17 07:00","pubTimestamp":1773702043,"startTime":"0","endTime":"0","summary":"China Medical System proposed a final ordinary dividend of CNY 0.14 per share for the year ended Dec. 31, 2025. Shareholders will vote on the proposal on April 23, 2026. The dividend is expected to be paid at HKD 0.16 per share. The ex-dividend date is April 27, 2026, and the record date is April 29, 2026. Payment is scheduled for May 7, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDLbqLVJd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","SG9999004220.SGD","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999015952.SGD","00867","IE00BVYPNP33.GBP","LU2488822045.USD","SG9999015945.SGD","SG9999015978.USD","IE00BYV24P56.USD","BK1191","IE00BMCWC346.EUR","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"1101869571","title":"CMS (00867) FY2025: Turnover Up 9.9% to RMB 8.21 Billion, Normalised Profit Rises 3.6%; Pipeline Advances with 2 Approvals and 6 NDAs","url":"https://stock-news.laohu8.com/highlight/detail?id=1101869571","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101869571?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:02","pubTimestamp":1773673326,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (CMS, 00867 HK; 8A8 SG) reported audited results for the year ended 31 December 2025. Financial Performance   • Turnover grew 9.9% year-on-year to RMB 8.21...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"gpt_icon":0},{"id":"1187030708","title":"CMS Reports 2025 Financial Results: Profit Attributable to Owners Declines 8.08% to Approximately 1.489 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1187030708","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187030708?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:56","pubTimestamp":1773672998,"startTime":"0","endTime":"0","summary":"CMS announced its 2025 financial performance, with revenue increasing by 9.95% year-over-year to 8.212 billion yuan. Profit attributable to owners was approximately 1.489 billion yuan, a decrease of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867","SG9999015952.SGD","SG9999015945.SGD","BK1191","SG9999015978.USD","IE00BVYPNP33.GBP","BK1593","SG9999004220.SGD","IE00BVYPNQ40.USD","LU2488822045.USD","IE00BMCWC346.EUR","SG9999015986.USD","IE00BGHQDM52.EUR","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2619546435","title":"China Medical System FY2025 profit fell 10.5% to RMB1.44 billion as turnover rose 9.9% to RMB8.21 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2619546435","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619546435?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:44","pubTimestamp":1773672290,"startTime":"0","endTime":"0","summary":"China Medical System published an annual results announcement reporting FY2025 turnover up 9.9% to RMB8.21 billion. FY2025 gross profit rose 8.3% to RMB5.87 billion, while profit for the year fell 10.5% to RMB1.44 billion. Basic earnings per share declined 7.8% to RMB0.6154, and bank balances and cash were RMB2.7 billion at Dec. 31, 2025. The company proposed a FY2025 final dividend of RMB0.1366 per share, bringing the FY2025 total dividend up 9% to RMB0.2921 per share. Management said FY2025 profit was affected by non-recurring and non-operational items, including a one-off RMB278.8 million payment related to repayment of a local income tax concession for 2022-2024 and a late payment surcharge.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDLbF9BGz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004220.SGD","SG9999015978.USD","BK1593","SG9999015952.SGD","LU2488822045.USD","00867","BK1191","IE00BYV24P56.USD","SG9999015986.USD","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","SG9999015945.SGD","IE00BVYPNQ40.USD"],"gpt_icon":0},{"id":"2619046433","title":"China Medical System Holdings -  Profit for Year RMB1,443.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2619046433","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619046433?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:44","pubTimestamp":1773672263,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nFWN4040GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","00867","IE00BGHQDM52.EUR","SG9999015986.USD","IE00BVYPNQ40.USD","SG9999004220.SGD","IE00BYV24P56.USD","BK1191","IE00BVYPNP33.GBP","LU2488822045.USD","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015978.USD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2619464331","title":"China Medical System Holdings - Proposed Final Dividend of RMB0.1366 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2619464331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619464331?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:44","pubTimestamp":1773672255,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nFWN4040IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BVYPNQ40.USD","SG9999004220.SGD","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","IE00BYV24P56.USD","LU2488822045.USD","SG9999015986.USD","SG9999015978.USD","BK1191","00867","SG9999015952.SGD","SG9999015945.SGD","IE00BMCWC346.EUR","BK1593"],"gpt_icon":0},{"id":"2619483124","title":"Assessing China Medical System (SEHK:867) Valuation After A Recent Share Price Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2619483124","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619483124?lang=en_us&edition=fundamental","pubTime":"2026-03-14 22:25","pubTimestamp":1773498313,"startTime":"0","endTime":"0","summary":"Recent share performance and business snapshot\nChina Medical System Holdings (SEHK:867) has drawn investor attention after a recent share price pullback, with the stock posting a 4.1% decline over the past day and a 16.3% decline over the past month.\nOver the past 3 months, the stock has recorded a 6.3% decline, while the 1 year total return stands at 55.1%. In the longer term, the 3 year total return is 13.4% and the 5 year total return reflects a 12.3% decline.\nThe company reports annual...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/assessing-china-medical-system-sehk867-valuation-after-a-rec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/assessing-china-medical-system-sehk867-valuation-after-a-rec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1593","IE00BYV24P56.USD","SG9999015945.SGD","SG9999015952.SGD","IE00BVYPNQ40.USD","BK1191","SG9999004220.SGD","DCF","SG9999015986.USD","00867","LU2488822045.USD","IE00BVYPNP33.GBP","SG9999015978.USD","IE00BGHQDM52.EUR","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2619118902","title":"China Medical System Holdings - Nmpa Approves Desidustat Tablets for Renal Anaemia in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2619118902","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619118902?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:54","pubTimestamp":1773410083,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN4010L0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BVYPNQ40.USD","SG9999004220.SGD","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","IE00BYV24P56.USD","LU2488822045.USD","SG9999015986.USD","SG9999015978.USD","BK1191","00867","SG9999015952.SGD","SG9999015945.SGD","IE00BMCWC346.EUR","BK1593"],"gpt_icon":0},{"id":"2619192249","title":"China Medical System Gets China Nod to Market Renal Anaemia Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2619192249","media":"MT Newswires","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619192249?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:35","pubTimestamp":1773405323,"startTime":"0","endTime":"0","summary":"China Medical System (HKG:0867, SGX:8A8) obtained marketing approval for renal anaemia drug Desidustat Tablets from China's National Medical Products Administration,The product is used for treating anaemia in non-dialysis adult patients with chronic kidney disease.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999004220.SGD","8A8.SI","IE00BVYPNP33.GBP","SG9999015945.SGD","IE00BMCWC346.EUR","BK1593","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015986.USD","BK6079","00867","SG9999015978.USD","SG9999015952.SGD","BK1191"],"gpt_icon":0},{"id":"1143602131","title":"CMS Gains Chinese Approval for New Anemia Drug Desidustat","url":"https://stock-news.laohu8.com/highlight/detail?id=1143602131","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143602131?lang=en_us&edition=fundamental","pubTime":"2026-03-13 18:49","pubTimestamp":1773398986,"startTime":"0","endTime":"0","summary":"CMS (00867) announced that the marketing authorization application for its new renal anemia drug, Desidustat Tablets, was approved by China's National Medical Products Administration (NMPA) on March...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004220.SGD","IE00BVYPNP33.GBP","BK1191","IE00BGHQDM52.EUR","BK1593","SG9999015986.USD","00867","IE00BMCWC346.EUR","SG9999015945.SGD","IE00BYV24P56.USD","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015952.SGD","SG9999015978.USD"],"gpt_icon":0},{"id":"2619919663","title":"China Medical System Holdings -  New Drug for Renal Anaemia Desidustat Tablets Approved for Marketing by China Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2619919663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619919663?lang=en_us&edition=fundamental","pubTime":"2026-03-13 18:44","pubTimestamp":1773398652,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN40104G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999004220.SGD","SG9999015945.SGD","IE00BVYPNQ40.USD","BK1593","SG9999015978.USD","IE00BGHQDM52.EUR","00867","IE00BYV24P56.USD","SG9999015986.USD","BK1191","IE00BVYPNP33.GBP","SG9999015952.SGD","IE00BMCWC346.EUR","LU2488822045.USD"],"gpt_icon":0},{"id":"2619196686","title":"China Medical System says China approves Desidustat tablets for CKD anaemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2619196686","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619196686?lang=en_us&edition=fundamental","pubTime":"2026-03-13 18:43","pubTimestamp":1773398599,"startTime":"0","endTime":"0","summary":"China Medical System said China’s NMPA approved Desidustat tablets for treating anaemia in non-dialysis adult chronic kidney disease patients. The drug is an oral HIF-PHI that increases endogenous erythropoietin and improves iron availability. China Medical System’s subsidiary CMS International Development and Management obtained an exclusive license for Desidustat from Zydus Lifesciences under a license agreement effective 20 January 2020.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 13, 2026, and is solely responsible for the information conta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL2wxX6M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004220.SGD","00867","IE00BVYPNP33.GBP","SG9999015978.USD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","IE00BYV24P56.USD","SG9999015952.SGD","SG9999015945.SGD","BK1191","SG9999015986.USD","LU2488822045.USD","BK1593","IE00BMCWC346.EUR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":0.0614},{"period":"1month","weight":-0.12},{"period":"3month","weight":0.015},{"period":"6month","weight":-0.1019},{"period":"1year","weight":0.7929},{"period":"ytd","weight":0.0457}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.0161},{"period":"6month","weight":-0.0478},{"period":"1year","weight":0.0437},{"period":"ytd","weight":-0.0138}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.010984},{"month":2,"riseRate":0.6,"avgChangeRate":0.034663},{"month":3,"riseRate":0.4375,"avgChangeRate":-0.006957},{"month":4,"riseRate":0.533333,"avgChangeRate":0.029521},{"month":5,"riseRate":0.466667,"avgChangeRate":0.01146},{"month":6,"riseRate":0.666667,"avgChangeRate":0.005887},{"month":7,"riseRate":0.533333,"avgChangeRate":-0.008683},{"month":8,"riseRate":0.4,"avgChangeRate":0.021846},{"month":9,"riseRate":0.466667,"avgChangeRate":0.00566},{"month":10,"riseRate":0.5,"avgChangeRate":0.008421},{"month":11,"riseRate":0.5625,"avgChangeRate":0.054281},{"month":12,"riseRate":0.5625,"avgChangeRate":0.03433}],"exchange":"SEHK","name":"CMS","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CMS(00867) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CMS,00867,CMS股票,CMS股票老虎,CMS股票老虎国际,CMS行情,CMS股票行情,CMS股价,CMS股市,CMS股票价格,CMS股票交易,CMS股票购买,CMS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CMS(00867) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}